Capital Markets: Equity (International Firms)

About

Provided by Slaughter and May

We are proud of our reputation as the go-to Equity Capital Markets practice for the most significant, complex and novel listings on the market. We have extensive experience of equity and debt capital markets transactions, handling primary and secondary offerings, where we act for both issuers and underwriters. Unlike our peers that focus purely on volume work, we are renowned for our ability to help clients navigate uncharted and complex matters amid an increasingly regulated and geopolitical landscape.

One of our key strengths is our extensive working relationship with and significant experience and knowledge of the working practices and policies of the HKEX and the SFC. This enables us to draw on a deep well of regulatory expertise, reflected in several of our partners current/past positions in various committees and regulatory authorities in Hong Kong. We have considerable experience dealing with regulators on a wide range of policy-related listing issues, including pre-revenue biotech listings, weighted voting rights, overseas issuers, homecoming listings, SPACs, Main Board listing criteria and suitability issues.

We provide seamless U.S., Hong Kong and English law capabilities for capital markets transactions in Hong Kong.